97 related articles for article (PubMed ID: 29185270)
1. Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.
Ayhan A; Ozkan NT; Sarı ME; Celik H; Dede M; Akbayır Ö; Güngördük K; Şahin H; Haberal A; Güngör T; Arvas M; Meydanlı MM
J Gynecol Oncol; 2018 Jan; 29(1):e12. PubMed ID: 29185270
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study.
Oktar O; Korkmaz V; Tokalıoğlu A; Öztürk Ç; Erdoğan Ö; Uçar Y; Koca Yıldırım HE; Hanedan C; Kılıç F; Ersak B; Yalçın N; Özmen F; Kahraman A; Esen SA; Baş S; Özdaş ED; Selçuk İ; Uçar G; Koçak Ö; Çakır C; Koç S; Kılıç Ç; Cömert GK; Üreyen I; Toptaş T; Narin MA; Taşçı T; Taşkın S; Boran N; Sancı M; Köş FT; Tekin ÖM; Üstün YE; Ortaç F; Turan T
J Gynecol Oncol; 2024 May; 35(3):e39. PubMed ID: 38156722
[TBL] [Abstract][Full Text] [Related]
4. Twenty-five Years Overall Survival Prognostic Value of the Lymph Node Ratio in
Gorobets O; Keam B; Vinh-Hung V; Nguyen NP
Anticancer Res; 2024 May; 44(5):1995-2002. PubMed ID: 38677759
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer.
Zhuo M; Tian L; Han T; Liu TF; Lin XL; Xiao XY
World J Gastrointest Oncol; 2024 Mar; 16(3):833-843. PubMed ID: 38577470
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer.
Park K; Kwon JY; Song JM; Pyeon SY; Lee SH; Chung YS; Lee JM
PLoS One; 2024; 19(5):e0299205. PubMed ID: 38805507
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis in pT1-3 and paracolic lymph-node invasion colorectal cancer: the prognostic role of positive paracolic lymph-node ratio for adjuvant chemotherapy.
Feng X; Liao W; Tang Y; Yi X; Tian T; Li H; Lin J; Lu X; Wan J; Wang J; Deng H; Chen C; Diao D
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38782864
[TBL] [Abstract][Full Text] [Related]
8. Redefining the standard of care for low-grade serous ovarian cancer.
Manning-Geist BL; Cantor T; O'Cearbhaill RE; Grisham RN
Clin Adv Hematol Oncol; 2024 Jun; 22(5):205-226. PubMed ID: 38805312
[TBL] [Abstract][Full Text] [Related]
9. Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario.
McGee J; Panabaker K; Leonard S; Ainsworth P; Elit L; Shariff SZ
Int J Gynecol Cancer; 2017 Mar; 27(3):437-443. PubMed ID: 28072594
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor deposits and positive lymph node ratio in stage III colorectal cancer: a retrospective cohort study.
Liu L; Ji J; Ge X; Ji Z; Li J; Wu J; Zhu J; Yao J; Zhu F; Mao B; Cao Z; Zhou J; Miao L; Ji G; Hang D
Int J Surg; 2024 Mar; ():. PubMed ID: 38498367
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients.
Chen M; Yao S; Cao Q; Xia M; Liu J; He M
Oncotarget; 2017 Dec; 8(64):107877-107885. PubMed ID: 29296209
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
Yang EJ; Lee AJ; Hwang WY; Chang SJ; Kim HS; Kim NK; Kim Y; Kong TW; Lee EJ; Park SJ; Son JH; Suh DH; Son DH; Shim SH
J Gynecol Oncol; 2024 Mar; ():. PubMed ID: 38497109
[TBL] [Abstract][Full Text] [Related]
13. First Reported Histologically and Molecularly Confirmed Bilateral High-Grade Serous Ovarian Adenocarcinoma Metastasized to Placental Decidua of the Membranes.
El Emrani S; Nooij LS; Lap CCMM; van der Meeren LE
Pediatr Dev Pathol; 2024; 27(3):270-274. PubMed ID: 38221679
[TBL] [Abstract][Full Text] [Related]
14. High-Grade Serous Ovarian Cancer during Pregnancy: From Diagnosis to Treatment.
Vivod G; Merlo S; Kovacevic N
Curr Oncol; 2024 Apr; 31(4):1920-1935. PubMed ID: 38668047
[TBL] [Abstract][Full Text] [Related]
15. Metastasis of serous ovarian carcinoma to the breast: a case report and review of the literature.
Dueño S; Stein R; Jamal M; Lewis G; Hew K
J Med Case Rep; 2024 Mar; 18(1):127. PubMed ID: 38528610
[TBL] [Abstract][Full Text] [Related]
16. Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer.
Sköld C; Corvigno S; Dahlstrand H; Enblad G; Mezheyeuski A; Sundström-Poromaa I; Stålberg K; Tolf A; Glimelius I; Koliadi A
Cancer Causes Control; 2024 Apr; ():. PubMed ID: 38578428
[TBL] [Abstract][Full Text] [Related]
17. Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.
van Lieshout L; van der Ploeg P; Wesseling-Rozendaal Y; van de Stolpe A; Bosch S; Lentjes-Beer M; Ottenheijm M; Meriaan A; Vos C; de Hullu J; Massuger L; Bekkers R; Piek J
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680250
[TBL] [Abstract][Full Text] [Related]
18. Update on Imaging of Ovarian Cancer.
Forstner R; Meissnitzer M; Cunha TM
Curr Radiol Rep; 2016; 4():31. PubMed ID: 27110476
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of ABO Blood Group on the Survival in Patients with Ovarian Cancer.
Zhou J; Yang LC; He ZY; Li FY; Wu SG; Sun JY
J Cancer; 2015; 6(10):970-5. PubMed ID: 26316893
[TBL] [Abstract][Full Text] [Related]
20. A Phase I Study of S-1-based Concurrent Chemoradiotherapy Followed by Gemcitabine and S-1 in Metastatic Pancreatic Adenocarcinoma.
Yang SH; Shao YY; Lin CC; Kuo SH; Cheng AL; Yeh KH
Anticancer Res; 2018 Aug; 38(8):4805-4812. PubMed ID: 30061252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
